According to Business Research Insights the Memantine Hydrochloride Tablets Market expected to exhibit a CAGR of 5.9% by 2033. The "Memantine Hydrochloride Tablets Market" Research is your essential ...

- Indicated for Treatment of Moderate to Severe Alzheimer's Disease - DUBLIN and EMERYVILLE, Calif., Dec. 24, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) and Adamas Pharmaceuticals Inc. (NASDAQ: ADMS ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved memantine/donepezil ...

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched Memantine hydrochloride tablets USP, 5 mg and 10 mg, a therapeutic equivalent generic ...

July 21, 2004 (Philadelphia) — Results of a phase III trial of memantine hydrochloride monotherapy in patients with mild to moderate Alzheimer's disease suggest that the drug is effective at all ...

The dementia drug memantine showed promise for improving social functioning in a small trial of youth with autism. Nine of 16 children and adolescents treated with memantine met the response criteria ...

It is a therapeutic equivalent generic version of NAMENDA (memantine HCl) tablets in the US market Dr Reddy’s Laboratories has launched memantine hydrochloride tablets USP, 5 mg and 10 mg, a ...

Actavis and Adamas Pharmaceuticals Inc announced that the US Food and Drug Administration (US FDA) has approved the New Drug Application (NDA) for Namzaric, a fixed-dose combination (FDC) of memantine ...

The rising number of pipeline studies related to the use of memantine is expected to drive the memantine market growth. For instance, in September 2016, Lille University Hospital started phase I ...

Please provide your email address to receive an email when new articles are posted on . Response rates on the SRS-2 and CGI-S were significantly higher in those given memantine. Memantine was also ...